{
    "organizations": [],
    "uuid": "aa275beefea885c0d3b62511d333c66f6ee62806",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-can-fite-submits-safety-reports-to/brief-can-fite-submits-safety-reports-to-fda-idUSASB0C6ZW",
    "ord_in_thread": 0,
    "title": "BRIEF-Can Fite Submits Safety Reports To FDA",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 22 (Reuters) - Can Fite Biopharma Ltd:\n* CAN FITE ANNOUNCES THE SUBMISSION OF SAFETY REPORTS FOR PICLIDENOSON AND NAMODENOSON TO FDA AND OTHER REGULATORY AUTHORITIES SHOWING FAVORABLE SAFETY PROFILE Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-22T21:16:00.000+02:00",
    "crawled": "2018-02-23T16:00:59.005+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "fite",
        "biopharma",
        "ltd",
        "fite",
        "announces",
        "submission",
        "safety",
        "report",
        "piclidenoson",
        "namodenoson",
        "fda",
        "regulatory",
        "authority",
        "showing",
        "favorable",
        "safety",
        "profile",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}